TATAA Biocenter Expands its Digital PCR offerings19th February
TATAA Biocenter Expands its Digital PCR offerings with Stilla Technologies unique 3-color Digital PCR System Naica
Göteborg, Sweden & Stilla, France, February 20, 2018
TATAA Biocenter, Europe´s leading provider of genomic services, is expanding its digital PCR offerings with Stilla Technologies unique 3 color digital PCR system Naica. “Digital PCR is the most important complement to qPCR and NGS and can be used for standardization, copy number variation, and rare mutation analysis,” said Dr. Mikael Kubista, founder and CEO of TATAA Biocenter. “We have previously adopted the Quantstudio 12K from ThermoFisher, and the BioMark from Fluidigm, which offer simultaneous measurements of qPCR and highly specific and sensitive dPCR analysis, and QX200 from Bio-Rad and QuantStudio 3D from ThermoFisher that offer dPCR in high throughput, using a much larger number of partitions. With this addition of the Naica system we can also offer the power of 3-color digital PCR. This is major strengthening of our service and training offerings.”
Stilla Technologies is thrilled to partner with TATAA Biocenter on extending TATAA’s current offer on genomic service and hands-on digital PCR training courses. “Our system has some unique features, in particular its 3-color multiplexing capability, that provide users extended analytical power in digital PCR. We believe that these innovations, and digital PCR in general, will open new perspectives in the field of genetics,” said Magali Droniou, co-founder and Applications Director of Stilla Technologies. “This will happen only if we, as a technology provider, set education and training as one of the company’s key missions. In this effort, joining forces with TATAA Biocenter makes full sense.”
About Stilla Technologies
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing innovative instrumentation for digital PCR (dPCR).
In 2016, Stilla Technologies launched the Naica System, the first and only digital PCR solution to offer 3-color multiplexing. By encapsulating all steps for digital PCR in a single chip, the Naica System offers a fast and user-friendly solution, rendering digital PCR accessible to all.
Stilla advises and supports its customers worldwide with a proactive and multidisciplinary R&D
team, whose expertise ranges from microfluidics and chemistry, to molecular biology and computer
science. Visit us at www.stillatechnologies.com.
About TATAA Biocenter
TATAA Biocenter is world’s largest organizer of hands-on training in molecular analyses and
Europe’s leading provider of nucleic acid analysis services in compliance with ISO17025 standard.
In 2007 TATAA Biocenter was the first company in Europe to provide digital PCR services to
researchers and published in 2008 one of the first papers featuring an application of digital PCR on
a high throughput platform (Nucleic Acids Research 36: 387, 2008). TATAA experts also coauthored
the Guidelines for Minimum Information for Publication of Quantitative Digital PCR
Experiments (Clinical Chemistry 59:6, 2013). Founded in 2001, TATAA has permanent facility in
Gothenburg, Sweden, and Prague, Czech Republic. In 2013 TATAA was presented the Frost &
Sullivan Award for Customer Value Leadership as Best-in-Class Services for Analyzing Genetic
Material. Visit us at www.tataa.com.
Publication – SENSE RNA-Seq Library Prep Kit15th February
Interesting results from Uppsala University and KI, obtained using the SENSE RNA-Seq Library Prep Kit from Lexogen:
Job openings12th December
Molecular microbiological identification and typing22nd November
Molecular microbiological identification and typing
TATAA Biocenter are proud to collaborate with RISE Research Institutes of Sweden and invites you to our course.
Course date: 17-18 Januari 2018. The courses start at 9 am and ends between 4.30 and 5.30 pm.
Registration deadline: 2 January 2018.
Course Language: Course will be held in English. Lecturers are Swedish.
- Day 1, RISE, Jordbruk och livsmedel, Frans Perssons väg 6, Göteborg
- Day 2, TATAA Biocenter, Odinsgatan 28, Göteborg
Responsible teachers: Charlotta Löfström PhD, Erik Nygren PhD, Johanna Edlund MSc, Filip Stern PhD
Number of students: Up to 15 students
Course fee: 2 days theoretical course inclusive laboratory experiment, 9000 SEK/attendee (excluded VAT). The course fee includes tuition, course materials, lunch, beverage, light snack, and fruits. Course fees DO NOT include accommodation, airfare or other travel costs.
Molecular analysis methods used for identification and typing of microorganisms are important to determine properties of the microbial strain, e.g. antimicrobial resistance, or to trace outbreaks in the food production chain. In recent years, novel technologies have been introduced based on thorough investigations of the nucleic acid content (DNA/RNA) of the microorganism.
This course provides you with an overview of some of these techniques and gives advice on how to interpret the complex data that are generated. The course focuses on quantitative PCR, whole genome sequencing and metagenomics. Some examples of software and approaches to data analysis of sequencing data will be provided.
Who should attend this course?
The target group for this course includes persons with experience with microbiological analysis methods in e.g. the food or pharmaceutical industry, who needs increased knowledge about methods used for microbial identification, with focus on new DNA/RNA based analysis techniques.
We recommend that you have good knowledge and experience with microbiological laboratory work.
After attending this course, participants will have obtained knowledge about molecular methods for identification and typing of microorganisms.
Focus in the course is on novel molecular techniques such as qPCR, whole genome sequencing and metagenomics. Some tools for data analysis will also be demonstrated.
End-of-year offer!16th November
Offer: Pick products from at least 2 of the workflow steps below:
RNA extraction solutions
- All RNA extraction kits from Norgen Biotek
- CelluLyser™ Lysis and cDNA Synthesis Kit
- CelluLyser™ Micro Lysis and cDNA Synthesis Kit
Quality control products
- Reference Gene Panels – find the most stable reference genes
- ValidPrime® – control for gDNA background
- TATAA Universal RNA and DNA Spikes – control for inhibition
- TATAA Interplate Calibrator – compensate for variations between qPCR runs
- Heat&Run gDNA Removal Kit
- PCR Decontamination Kit
- TATAA DeltaAmp Quality assay – a new molecular method to assess RNA/DNA integrity with qPCR
- VisiBlue™ – qPCR Mix Colorant
- BOXTO – control for Primer Dimers in Probe based qPCR assays
cDNA synthesis and qPCR reagents
- TATAA GrandScript cDNA Synthesis Kit
- TATAA GrandScript cDNA SuperMix
- TATAA GrandMaster and GenMaster mixes
*The 22% discount is valid for orders placed 16th of November to 20th of December 2017. Order directly from TATAA Biocenter in our webshop (webshop.tataa.com) or by e-mail to firstname.lastname@example.org, the discount will show in the order confirmation. The discount cannot be combined with other offers or discounts.
Expression profiling of circulating tumor cells13th October
Researchers from University of Essen in collaboration with Qiagen and TATAA stratify breast cancer patients based on expression profiling of circulating tumor cells
Circulating tumor cells (CTC) are thought to be an ideal surrogate marker to monitor disease progression in metastatic breast cancer (MBC).We investigated the prediction of treatment response in CTC of MBC patients on the basis of the expression of 46 genes.
CTCs are proposed to be an attractive source of liquid biopsy markers for monitoring disease progression. CTCs are highly heterogeneous and can change in number and phenotype under anticancer treatment. Stem cell-like tumor cells, undergoing epithelial-mesenchymal-transition (EMT) and not displaying the classical epithelial phenotype, are discussed as an active source of metastatic spread and have been identified within the population of CTCs.
Press release – Mic28th September
TATAA Biocenter Expands its real-time PCR offerings with the Mic from Bio Molecular Systems
Gothenburg. Sweden, and Upper Coomera, Australia, September 28, 2017
TATAA Biocenter, the world´s leading provider of hands-on training in molecular analyses, expands its qPCR instrument park with the Mic from Bio Molecular Systems. “People come from all around the world to TATAA for qPCR training and they expect getting chance to try out the best qPCR instruments there are. The Mic is certainly one of them and it will be most attractive option for those with space limitations. Also, with no moving parts, the Mic is essentially calibration free.” says Dr. Mikael Kubista, founder and CEO of TATAA Biocenter. TATAA Biocenter courses are arranged around the world supported by leading instrument and solution providers in molecular analyses. TATAA is also instrumental in quality control and standardization of molecular testing, being member of the European efforts SPIDIA (www.spidia.eu) and CANCER-ID (www.cancer-id.eu) standardizing the preanalytical steps and blood based analyses, respectively. “We are very proud of the collaboration with TATAA Biocenter. Now, users have the possibility to compare the Mic with traditional qPCR instruments and appreciate its advantages.”, says John Corbett, CEO of Bio Molecular Systems.
About TATAA Biocenter
TATAA Biocenter is world’s prime organizer of hands-on training in molecular diagnostics, Europe’s leading provider of nucleic acid analysis services, and Sweden’s most comprehensive distributor of products for quality control in nucleic acids testing. TATAA has the best equipped laboratories for qPCR based analysis in Europe, and provides full range of nucleic acids and protein analyses services using qPCR, dPCR, microarray and NGS to pharmaceutical and biotech companies in compliance with ISO 17025 standard. Founded in 2001, TATAA has facilities in Gothenburg, Sweden and Prague, Czech Republic. In 2013 TATAA was presented the Frost & Sullivan Award for Customer Value Leadership as Best-in-Class Services for Analyzing Genetic Material.
About BIO Molecular Systems
Bio Molecular Systems (BMS) is a biotechnology company that designs, manufactures and distributes instrumentation for the life sciences. Established in 2010 and comprising of the founders and senior personnel from the former Corbett Life Sciences company, BMS has the expertise in developing innovative, versatile, robust, and easy-to-use products that generate strong customer loyalty. Our long-standing position in the biotech manufacturing sector enables us to establish a reputation for continuous and rapid in-house innovation and product evolution.
BMS has an R&D and manufacturing facility located within the Gold Coast area just 50 minutes south of the city of Brisbane (Queensland, Australia). Our facilities contain state of the art technology for both R&D engineering and manufacturing. We also have a second site in Sydney used to conduct all applications testing. By directly controlling all phases of production, we optimise quality control, minimise overhead costs and ensure the most rapid product development cycles.
For more information:
Comparison of WGA techniques for human single cell exome sequencing22nd September
Comparison of WGA techniques for human single cell exome sequencing
Whole genome amplification (WGA) is currently a prerequisite for single cell whole genome or exome sequencing. Depending on the method used the rate of artifact formation, allelic dropout and sequence coverage over the genome may differ significantly.
TATAA Biocenter is a proud distributor of the MALBAC kits and are pleased too see that MALBAC had the highest fidelity for both exome coverage and variant calling!
“The largest difference between the evaluated protocols was observed when analyzing the target coverage and read depth distribution. These differences also had impact on the downstream variant calling. Conclusively, the products from the AMPLI1 and MALBAC kits were shown to be most similar to the bulk samples and are therefore recommended for WGA of single cells.”
Comparison of whole genome amplification techniques for human single cell exome sequencing
Erik Borgström, Marta Paterlini, Jeff E. Mold, Jonas Frisen, Joakim Lundeberg
Published: February 16, 2017, https://doi.org/10.1371/journal.pone.0171566
Gothenburg. Sweden, and Jena, Germany, August 17, 2017
TATAA Biocenter Expands its real-time PCR offerings with Analytik Jena´s qTOWER3
TATAA Biocenter, the world´s leading provider of hands-on training in molecular analyses, expands its qPCR instrument park with Analytik Jena´s qTOWER3. “People come from all around the world to TATAA to be trained in qPCR, and they expect getting chance to try out the best qPCR instruments there are. The qTOWER3 is certainly one of them and it will become an attractive option to those looking for a new instrument.” says Dr. Mikael Kubista, founder and CEO of TATAA Biocenter. TATAA Biocenter courses are arranged around the world and supported by all the leading instrument and solution providers in molecular analyses. TATAA is also instrumental in quality control and standardization of molecular testing, being member of the European efforts SPIDIA (www.spidia.eu) and CANCER-ID (www.cancer-id.eu) standardizing the preanalytical steps and blood based analyses, respectively. “We are very proud of the collaboration with TATAA Biocenter. Now, we have the possibility to compare the qTOWER³ to similar qPCR instruments on the market. It is perfect for us to give users opportunity to test it head-to-head to other instruments on the market at the TATAA courses”, says Melanie Jahn, product manager at Analytik Jena.
About TATAA Biocenter
TATAA Biocenter is world’s largest organizer of hands-on training in molecular diagnostics, Europe’s leading provider of nucleic acid analysis services, and Sweden’s most comprehensive distributor of products for quality control in nucleic acids testing. TATAA has the best equipped laboratories for qPCR based analysis in Europe, and provides full range of nucleic acids and protein analyses services using qPCR, dPCR, microarray and NGS to pharmaceutical and biotech companies in compliance with ISO 17025 standard. Founded in 2001, TATAA has facilities in Gothenburg, Sweden and Prague, Czech Republic. In 2013 TATAA was presented the Frost & Sullivan Award for Customer Value Leadership as Best-in-Class Services for Analyzing Genetic Material.
About Analytik Jena
Analytik Jena is a provider of instruments and products in the areas of analytical measuring technology and bioanalytical applications. The life science portfolio provides a wide spectrum for automated as well as individual solutions for molecular biology. The products are focused to offer quality and reproducibility of the laboratory results and encompasses powerful device systems and over 500 reagents and kits, including those for nucleic acid extraction, PCR, qPCR and pathogen analyses. The company’s in-house expertise is protected by more than 150 patents.
For more information see:
Olink Proteomics Webinar15th August
“Proteogenomic strategies to advance drug development and precision medicine”
TATAA Biocenter’s partner Olink Proteomics are sponsoring a Science/AAAS-hosted webinar: Gain new insights into how proteomics and genomics are now increasingly joining forces to improve the clinical utility of protein biomarkers and to enhance drug development strategies.
When? Wednesday September 6, 2017 at 12:00 pm U.S. Eastern Time/18:00 Central European Time
This free event will feature presentations from Professor Ulf Gyllensten (Uppsala University) & Dr. Anders Mälarstig (Pfizer Sweden)
During the webinar, the speakers will:
- Discuss how covariates (genetic, environmental, and clinical) can affect the levels of potential biomarkers
- Explore the use of covariate modeling to establish personally normalized plasma protein profiles (PNPPP) to reduce non-disease-related variation and maximize clinical potential
- Describe how protein quantitative trait loci (pQTLs) can provide insights into disease biology and improve the efficiency of drug development
- Answer your questions live during the broadcast!